0.0812 USD
0 (-5.58%)
0.078 USD
0 (-3.94%)
ChartMill assigns a Buy % Consensus number of 43% to CLVS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.04. This target is 2412.32% above the current price.
CLVS was analyzed by 7 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about CLVS.
In the previous month the buy percentage consensus was at a similar level.
CLVS was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-10 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-05-06 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-05-05 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-21 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-05 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-05 | HC Wainwright & Co. | Maintains | Buy |
CLOVIS ONCOLOGY INC / CLVS FAQ
What do analysts expect the price target to be for CLOVIS ONCOLOGY INC (CLVS)?
7 analysts have analysed CLVS and the average price target is 2.04 USD. This implies a price increase of 2412.32% is expected in the next year compared to the current price of 0.0812.
Can you provide the consensus rating for CLOVIS ONCOLOGY INC stock?
The consensus rating for CLOVIS ONCOLOGY INC (CLVS) is 42.8571 / 100 . This indicates that analysts generally have a neutral outlook on the stock.